Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Topical MOB015B for Distal Subungual Onychomycosis
NCT01814020Phase 2Completed
- Sponsor
- Moberg Pharma AB
- Start
- Dec 2012
- Primary completion
- Jul 2014
- Modality
- Transdermal Patches, Orthosteric Ligands, Hydrogel Systems
- Countries
- 1
01
Overview
A Phase 2 trial of MOB-015 in onychomycosis, sponsored by Moberg Pharma AB. Started Dec 2012; status: completed.
02
Drugs
MOB-015
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT01814020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01814020.